[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BioMedWire BioMedWire BioMedWire posts on X about $mrk, $azn, $10billion, investment the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1275894206469267456/interactions)  - X Week XXXXX +14% - X Month XXXXX +93% - X Months XXXXXX +73% - X Year XXXXXX +111% ### Mentions: X [#](/creator/twitter::1275894206469267456/posts_active)  - X Week XX +4.20% - X Month XX +14% - X Months XXX +30% - X Year XXX +55% ### Followers: XXXXX [#](/creator/twitter::1275894206469267456/followers)  - X Week XXXXX -XXXX% - X Month XXXXX +0.39% - X Months XXXXX +0.78% - X Year XXXXX +0.70% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1275894206469267456/influencer_rank)  ### Social Influence [#](/creator/twitter::1275894206469267456/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [currencies](/list/currencies) XXXX% [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$mrk](/topic/$mrk) 4.13%, [$azn](/topic/$azn) 4.13%, [$10billion](/topic/$10billion) 1.65%, [investment](/topic/investment) 1.65%, [acquisition](/topic/acquisition) 1.65%, [tariffs](/topic/tariffs) 0.83%, [$50b](/topic/$50b) 0.83%, [louder](/topic/louder) 0.83%, [stockmarket](/topic/stockmarket) 0.83%, [20m](/topic/20m) XXXX% **Top accounts mentioned or mentioned by** [@intuitivesurgs](/creator/undefined) [@ladymarketok](/creator/undefined) **Top assets mentioned** [Merck & Co., Inc. (MRK)](/topic/$mrk) [AstraZeneca PLC (AZN)](/topic/$azn) [MetaBeat (BEAT)](/topic/$beat) ### Top Social Posts [#](/creator/twitter::1275894206469267456/posts) --- Top posts by engagements in the last XX hours "$MRK is acquiring Verona Pharma in a $XX billion deal to strengthen its COPD pipeline with Ohtuvayre marking a big move into respiratory care: #pharma #COPD #Merck #biotech $MRK"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1948382833203892723) 2025-07-24 14:00:41 UTC 1300 followers, XX engagements "$AZN pledges $50B US investment by 2030new Virginia plant expanded R&D and celltherapy sites across multiple statesall in response to looming tariffs: #AstraZeneca #pharma #USinvest #tariffs"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1947718365742588361) 2025-07-22 18:00:19 UTC 1295 followers, XXX engagements "$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1945544045796762094) 2025-07-16 18:00:21 UTC 1295 followers, XX engagements "$J&J EVP of Innovative Medicine just picked up US$2.0m worth of stockshowing strong insider confidence. Moves like this often speak louder than words: #JNJ #StockMarket #InsiderBuying #PharmaStocks #JohnsonAndJohnson"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1947355974366339523) 2025-07-21 18:00:19 UTC 1300 followers, XX engagements "$AZN new immune disorder treatment shows success in late-stage trials offering hope for patients with rare conditions. A major step forward in targeted therapies: #AstraZeneca #ImmuneHealth #RareDiseases #BiotechNews #ClinicalTrials"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1948443135115182458) 2025-07-24 18:00:18 UTC 1298 followers, XX engagements "$AZN pledges a $XX billion investment in US by 2030building new manufacturing and R&D hubs (Virginia Maryland MA CA IN TX) to boost drug production & jobs : #Pharma #Investing #MadeInUSA #Biotech #Healthcare"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1948080723744710837) 2025-07-23 18:00:12 UTC 1299 followers, XX engagements "$MRK seals $10B deal for Verona Pharma gaining Ohtuvayre a first-in20years COPD inhaler. Big boost to its respiratory pipeline preKeytruda patent cliff: #Merck #VeronaPharma #COPD #PharmaDeals"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1948020428280082549) 2025-07-23 14:00:37 UTC 1298 followers, XX engagements "BioMedNewsBreaks $BEAT Wins 2025 Innovation Award for Remote Cardiac Diagnostics"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1947742231525245250) 2025-07-22 19:35:09 UTC 1295 followers, XX engagements "$AZN eco-friendly lung inhaler for smokers wins EU panel support marking a step toward greener respiratory care. Approval could follow soon: #AstraZeneca #GreenHealthcare #LungHealth #InhalerInnovation #SustainableMedicine"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1948805551158112515) 2025-07-25 18:00:25 UTC 1298 followers, XX engagements "$MRK expands its respiratory footprint with a $XX billion acquisition of Verona Pharma adding Ohtuvayre to its COPD portfolio as part of a strategic hedge ahead of Keytrudas patent expiry: #Merck #BiotechDeal #COPD #PharmaStrategy"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1948805551598502106) 2025-07-25 18:00:25 UTC 1298 followers, XX engagements "$MRK advances MK8527 into global Phase X trialsevaluating a oncemonthly oral PrEP pill across XX countries and a Gatesbacked study in subSaharan Africa: #HIVPrevention #PrEP #GlobalHealth #HIVResearch #Merck"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1946208509768425814) 2025-07-18 14:00:42 UTC 1299 followers, XX engagements "$MRK has closed its $3.4B acquisition of SpringWorks Therapeutics expanding its oncology pipeline and bolstering precision cancer treatments: #MerckAcquisition #Oncology #PrecisionMedicine #PharmaNews #BioPharma"  [@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1943671832885731570) 2025-07-11 14:00:51 UTC 1298 followers, 3462 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioMedWire BioMedWire
BioMedWire posts on X about $mrk, $azn, $10billion, investment the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +14%
- X Month XXXXX +93%
- X Months XXXXXX +73%
- X Year XXXXXX +111%
Mentions: X #
- X Week XX +4.20%
- X Month XX +14%
- X Months XXX +30%
- X Year XXX +55%
Followers: XXXXX #
- X Week XXXXX -XXXX%
- X Month XXXXX +0.39%
- X Months XXXXX +0.78%
- X Year XXXXX +0.70%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% currencies XXXX% finance XXXX% cryptocurrencies XXXX%
Social topic influence $mrk 4.13%, $azn 4.13%, $10billion 1.65%, investment 1.65%, acquisition 1.65%, tariffs 0.83%, $50b 0.83%, louder 0.83%, stockmarket 0.83%, 20m XXXX%
Top accounts mentioned or mentioned by @intuitivesurgs @ladymarketok
Top assets mentioned Merck & Co., Inc. (MRK) AstraZeneca PLC (AZN) MetaBeat (BEAT)
Top Social Posts #
Top posts by engagements in the last XX hours
"$MRK is acquiring Verona Pharma in a $XX billion deal to strengthen its COPD pipeline with Ohtuvayre marking a big move into respiratory care: #pharma #COPD #Merck #biotech $MRK"
@BioMedWire on X 2025-07-24 14:00:41 UTC 1300 followers, XX engagements
"$AZN pledges $50B US investment by 2030new Virginia plant expanded R&D and celltherapy sites across multiple statesall in response to looming tariffs: #AstraZeneca #pharma #USinvest #tariffs" @BioMedWire on X 2025-07-22 18:00:19 UTC 1295 followers, XXX engagements
"$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate" @BioMedWire on X 2025-07-16 18:00:21 UTC 1295 followers, XX engagements
"$J&J EVP of Innovative Medicine just picked up US$2.0m worth of stockshowing strong insider confidence. Moves like this often speak louder than words: #JNJ #StockMarket #InsiderBuying #PharmaStocks #JohnsonAndJohnson" @BioMedWire on X 2025-07-21 18:00:19 UTC 1300 followers, XX engagements
"$AZN new immune disorder treatment shows success in late-stage trials offering hope for patients with rare conditions. A major step forward in targeted therapies: #AstraZeneca #ImmuneHealth #RareDiseases #BiotechNews #ClinicalTrials" @BioMedWire on X 2025-07-24 18:00:18 UTC 1298 followers, XX engagements
"$AZN pledges a $XX billion investment in US by 2030building new manufacturing and R&D hubs (Virginia Maryland MA CA IN TX) to boost drug production & jobs : #Pharma #Investing #MadeInUSA #Biotech #Healthcare" @BioMedWire on X 2025-07-23 18:00:12 UTC 1299 followers, XX engagements
"$MRK seals $10B deal for Verona Pharma gaining Ohtuvayre a first-in20years COPD inhaler. Big boost to its respiratory pipeline preKeytruda patent cliff: #Merck #VeronaPharma #COPD #PharmaDeals" @BioMedWire on X 2025-07-23 14:00:37 UTC 1298 followers, XX engagements
"BioMedNewsBreaks $BEAT Wins 2025 Innovation Award for Remote Cardiac Diagnostics" @BioMedWire on X 2025-07-22 19:35:09 UTC 1295 followers, XX engagements
"$AZN eco-friendly lung inhaler for smokers wins EU panel support marking a step toward greener respiratory care. Approval could follow soon: #AstraZeneca #GreenHealthcare #LungHealth #InhalerInnovation #SustainableMedicine" @BioMedWire on X 2025-07-25 18:00:25 UTC 1298 followers, XX engagements
"$MRK expands its respiratory footprint with a $XX billion acquisition of Verona Pharma adding Ohtuvayre to its COPD portfolio as part of a strategic hedge ahead of Keytrudas patent expiry: #Merck #BiotechDeal #COPD #PharmaStrategy" @BioMedWire on X 2025-07-25 18:00:25 UTC 1298 followers, XX engagements
"$MRK advances MK8527 into global Phase X trialsevaluating a oncemonthly oral PrEP pill across XX countries and a Gatesbacked study in subSaharan Africa: #HIVPrevention #PrEP #GlobalHealth #HIVResearch #Merck" @BioMedWire on X 2025-07-18 14:00:42 UTC 1299 followers, XX engagements
"$MRK has closed its $3.4B acquisition of SpringWorks Therapeutics expanding its oncology pipeline and bolstering precision cancer treatments: #MerckAcquisition #Oncology #PrecisionMedicine #PharmaNews #BioPharma" @BioMedWire on X 2025-07-11 14:00:51 UTC 1298 followers, 3462 engagements